CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 178 enrolled
Drug / intervention
pyridostigmine +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00535587
NCT00535587Phase 2Completed
CompareCT.gov

Maximizing Exercise Effectiveness in Fibromyalgia

Oregon Health and Science University·interventional·Posted Sep 26, 2007·Updated Apr 18, 2011

In Brief

A Phase 2 clinical trial evaluating Exercise, pyridostigmine, and 2 other interventions for Fibromyalgia. Completed, enrolled 178 participants across 1 site.

Detailed Summary

The purpose of this trial was to test the combined and independent effects of 6 months of exercise and Mestinon in people with fibromyalgia. Specifically, we wanted to determine if Mestinon helped people with fibromyalgia have an easier time exercising and if their symptoms improved by the end of the trial.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFibromyalgia
CountriesUnited States
CollaboratorsNational Institute of Nursing Research (NINR)

Timeline

Phase 2CompletedFinished
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 26, 2007
Enrollment StartSep 1, 2002
Primary CompletionJun 1, 2008
TodayJul 2, 2026
Enrollment to primary: 5.8 yearsPosted 18.8 years ago

Interventions

Exercisebehavioral

pyridostigminedrug

Placibodrug

Attention Controlbehavioral